However, it is conceivable that based on the high expression and prevalence of CSPG4 in melanoma at all disease stages and its restricted distribution in normal tissues, future research will likely incorporate CSPG4 as a target for novel vaccine approaches. This evidence concerns the gene CSPG4 and melanoma.